PMC3082484_01
MRI after sunitinib and sorafenib failure.
cro0004-0016-f01.jpg
PMC3082484_01_cro0004-0016-f01.jpg
F1
After 5 months of sorafenib therapy, an MRI revealed further progression at all sites (fig. 1; online suppl. video 1; see www.karger.com/doi/10.1159/000323804).
Partial remission after 9 months on temsirolimus.
cro0004-0016-f02.jpg
PMC3082484_01_cro0004-0016-f02.jpg
F2
In July 2010, an impressive partial remission was documented by MRI (fig. 2; online suppl. video 2).